Supplementary Materials from A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Authors:
  • IMIngrid A. Mayer
    Ingrid A. Mayer
  • APAleix Prat
    Aleix Prat
  • DEDaniel Egle
    Daniel Egle
  • SBSibel Blau
    Sibel Blau
  • JFJ. Alejandro Pérez Fidalgo
    J. Alejandro Pérez Fidalgo
  • MGMichael Gnant
    Michael Gnant
  • PFPeter A. Fasching
    Peter A. Fasching
  • MCMarco Colleoni
    Marco Colleoni
  • AWAntonio C. Wolff
    Antonio C. Wolff
  • EWEric P. Winer
    Eric P. Winer
  • CSChristian F. Singer
    Christian F. Singer
  • SHSara Hurvitz
    Sara Hurvitz

Abstract
Contains supplementary tables and methods